Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Charter Communications
CHTR
|
+$768M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$625M |
| 3 |
AGN
Allergan plc
AGN
|
+$427M |
| 4 |
McKesson
MCK
|
+$427M |
| 5 |
Johnson Controls International
JCI
|
+$427M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Uber
UBER
|
+$503M |
| 2 |
RTX Corp
RTX
|
+$457M |
| 3 |
Global Payments
GPN
|
+$441M |
| 4 |
Amazon
AMZN
|
+$388M |
| 5 |
Johnson & Johnson
JNJ
|
+$355M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.1% |
| 2 | Healthcare | 3.97% |
| 3 | Industrials | 2.85% |
| 4 | Financials | 2.77% |
| 5 | Consumer Discretionary | 2.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4026
Xtrackers MSCI Japan Hedged Equity ETF
DBJP
$705M
| $1.91M | ﹤0.01% |
53,913
-8,387
| -13% | -$334K |
|
4027
TherapeuticsMD
TXMD
$24M
| $1.91M | ﹤0.01% |
36,060
+30,279
| +524% | +$3M |
|
4028
Direxion Daily FTSE China Bear 3X ETF
YANG
$89.2M
| $1.91M | ﹤0.01% |
2,105
-1,348
| -39% | -$1.23M |
|
4029
PUT
Novavax
NVAX
$1.31B
| $1.91M | ﹤0.01% |
140,500
+101,600
| +261% | +$860K |
|
4030
PUT
Ionis Pharmaceuticals
IONS
$9.4B
| $1.91M | ﹤0.01% |
40,300
-30,900
| -43% | -$1.72M |
|
4031
NOV
NOV
$7B
| $1.91M | ﹤0.01% |
193,786
-1,146,061
| -86% | -$21.6M |
|
4032
Blackbaud
BLKB
$2.08B
| $1.9M | ﹤0.01% |
34,269
+6,752
| +25% | +$478K |
|
4033
CALL
10x Genomics
TXG
$6.61B
| $1.9M | ﹤0.01% |
30,500
+15,600
| +105% | +$1.22M |
|
|
4034
PUT
Direxion Daily FTSE China Bear 3X ETF
YANG
$89.2M
| $1.9M | ﹤0.01% |
2,095
+1,270
| +154% | +$1.15M |
|
|
JOYY
4035
JOYY Inc
JOYY
$3.75B
| $1.9M | ﹤0.01% |
+35,678
| New | +$2.07M |
|
|
NVRO
4036
CALL
DELISTED
NEVRO CORP.
NVRO
| $1.9M | ﹤0.01% |
19,000
-21,900
| -54% | -$2.63M |
|
|
FLXN
4037
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $1.9M | ﹤0.01% |
241,244
-27,085
| -10% | -$408K |
|
|
TWOU
4038
PUT
DELISTED
2U Inc
TWOU
| $1.9M | ﹤0.01% |
2,980
-613
| -17% | -$414K |
|
4039
iShares MSCI Intl Value Factor ETF
IVLU
$4.55B
| $1.9M | ﹤0.01% |
107,737
-81,146
| -43% | -$1.76M |
|
4040
MillerKnoll
MLKN
$1.67B
| $1.9M | ﹤0.01% |
85,400
-71,221
| -45% | -$2.46M |
|
4041
PUT
MasTec
MTZ
$21.9B
| $1.89M | ﹤0.01% |
57,800
+30,000
| +108% | +$1.53M |
|
4042
Neogen
NEOG
$2.5B
| $1.89M | ﹤0.01% |
56,464
+26,228
| +87% | +$861K |
|
4043
Dorman Products
DORM
$4.18B
| $1.89M | ﹤0.01% |
34,219
-7,832
| -19% | -$533K |
|
|
LADR
4044
Ladder Capital
LADR
$1.24B
| $1.89M | ﹤0.01% |
398,865
+266,675
| +202% | +$4.05M |
|
4045
CALL
iShares MSCI ACWI ETF
ACWI
$33.5B
| $1.89M | ﹤0.01% |
30,200
+21,000
| +228% | +$1.56M |
|
4046
Direxion Daily FTSE China Bull 3X ETF
YINN
$745M
| $1.89M | ﹤0.01% |
8,145
+5,426
| +200% | +$1.9M |
|
4047
PUT
AerCap
AER
$23.8B
| $1.89M | ﹤0.01% |
82,900
-40,400
| -33% | -$1.99M |
|
4048
CALL
Western Alliance Bancorporation
WAL
$8.87B
| $1.89M | ﹤0.01% |
61,700
+5,800
| +10% | +$277K |
|
4049
CALL
Carlyle Group
CG
$17.2B
| $1.89M | ﹤0.01% |
87,200
+44,300
| +103% | +$1.28M |
|
|
BCPC
4050
Balchem Corp
BCPC
$5.72B
| $1.89M | ﹤0.01% |
19,129
+11,924
| +165% | +$1.22M |
|
Similar funds
Citadel Advisors's Q1 2020 Portfolio in Review
As of Q1 2020, Citadel Advisors held 10,687 positions worth $222B, down 3.5% from $230B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Citadel Advisors deployed $36.9B of net new capital in Q1 2020, opening 1,650 new positions and adding to 4,224 existing holdings. Its largest new stake was Invesco QQQ Trust: 2,950,335 shares worth $562M.
By sector, the portfolio is most concentrated in Technology at 4.1% of assets, down from 5.1% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Uber, an estimated $503M trimmed.
- Citadel Advisors's largest Q1 2020 buy was Invesco QQQ Trust: 2,950,335 shares worth $562M.
- Citadel Advisors added most to Charter Communications in Q1 2020, an estimated $768M increase.
- Citadel Advisors's biggest Q1 2020 reduction was Uber, cutting an estimated $503M.
- Citadel Advisors fully exited Zayo Group Holdings, Inc. in Q1 2020, selling an estimated $280M.
- Citadel Advisors's ten largest holdings make up 32% of its $222B portfolio in Q1 2020.
- Citadel Advisors opened 1,650 new positions and closed 1,165 in Q1 2020.
- Citadel Advisors's portfolio value fell 3.5% quarter-over-quarter to $222B.
Based on Citadel Advisors's 13F filing for Q1 2020, filed 15 May 2020.